Page last updated: 2024-08-17

lysine and ifosfamide

lysine has been researched along with ifosfamide in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gorlick, R; Hingorani, P; Kolb, EA; Lin, J; Piperdi, S; Pressman, L; Zhang, W	1
Jung, S; Kasper, B	1
Amedio, J; Jones, B; Komarnitsky, P; Miller, GT; Wallner, BP	1
Movva, S; Verschraegen, C	1

Reviews

2 review(s) available for lysine and ifosfamide

Article	Year
Palifosfamide, a bifunctional alkylator for the treatment of sarcomas. IDrugs : the investigational drugs journal, 2010, Volume: 13, Issue:1 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Ifosfamide; Lysine; Sarcoma; Soft Tissue Neoplasms	2010
Systemic management strategies for metastatic soft tissue sarcoma. Drugs, 2011, Nov-12, Volume: 71, Issue:16 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dioxoles; Doxorubicin; Gemcitabine; Humans; Ifosfamide; Lysine; Paclitaxel; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Trabectedin	2011

Other Studies

2 other study(ies) available for lysine and ifosfamide

Article	Year
Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:4 Topics: Animals; Antineoplastic Agents; Base Sequence; Cell Line, Tumor; DNA Primers; Drug Resistance, Neoplasm; Female; Gene Expression; Humans; Ifosfamide; Lysine; Mice; Mice, SCID; Osteosarcoma; Reverse Transcriptase Polymerase Chain Reaction	2009
Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin. Anti-cancer drugs, 2012, Volume: 23, Issue:2 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Ifosfamide; Injections, Intravenous; Leukemia, Experimental; Lysine; Male; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Phosphoramide Mustards; Rats; Rats, Sprague-Dawley; Taxoids; Xenograft Model Antitumor Assays	2012

Article

Year

Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma.

Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:4

Topics: Animals; Antineoplastic Agents; Base Sequence; Cell Line, Tumor; DNA Primers; Drug Resistance, Neoplasm; Female; Gene Expression; Humans; Ifosfamide; Lysine; Mice; Mice, SCID; Osteosarcoma; Reverse Transcriptase Polymerase Chain Reaction

2009

Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin.

Anti-cancer drugs, 2012, Volume: 23, Issue:2

Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Ifosfamide; Injections, Intravenous; Leukemia, Experimental; Lysine; Male; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Phosphoramide Mustards; Rats; Rats, Sprague-Dawley; Taxoids; Xenograft Model Antitumor Assays

2012